Home › Funds › Boston Common Asset Management, LLC › EW
Boston Common Asset Management, LLC position in EW
EDWARDS LIFESCIENCES CORP · Health Care
Boston Common Asset Management, LLC reported holding 173,996 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q3 2026 13F filing — a position valued at US$15.0M, representing 0.88% of its reported portfolio and ranking #28 among its reported holdings. Boston Common Asset Management, LLC has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR
How Boston Common Asset Management, LLC's EW position evolved
Boston Common Asset Management, LLC first disclosed a stake in EW in Q3 2023 at 235,420 shares (US$16.3M). The position peaked in Q1 2024 at 205,270 shares, worth US$19.6M. Across 13 filings, Boston Common Asset Management, LLC increased the stake 6 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 173,996 shares valued at US$15.0M — an increase of 13,182 shares quarter over quarter.. Notable position changes include a 27% trim in Q4 2024 (shares fell 2% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 235.42K | $16.31M | New |
| Q4 2023 | 226.11K | $17.24M | Reduce |
| Q1 2024 | 205.27K | $19.62M | Reduce |
| Q2 2024 | 199.95K | $18.47M | Reduce |
| Q3 2024 | 207.92K | $13.72M | Add |
| Q4 2024 | 152.53K | $11.29M | Reduce |
| Q1 2025 | 135.31K | $9.81M | Reduce |
| Q2 2025 | 150.86K | $11.80M | Add |
| Q3 2025 | 135.68K | $10.55M | Reduce |
| Q4 2025 | 149.55K | $12.75M | Add |
| Q1 2026 | 156.30K | $12.52M | Add |
| Q2 2026 | 160.81K | $14.55M | Add |
| Q3 2026 | 174.00K | $15.02M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EW and 13F data
EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 34 other funds we track also report a position in EW — the largest reported positions include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B), Aristotle Capital Management, LLC (US$783.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EW
- DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt 13.00M sh · $1.18B · Q2 2026
- Ninety One UK Ltd 11.94M sh · $1.03B · Q3 2026
- Aristotle Capital Management, LLC 8.67M sh · $783.91M · Q2 2026
- BROWN ADVISORY INC 7.37M sh · $666.33M · Q2 2026
- Artisan Partners Limited Partnership 6.63M sh · $599.36M · Q2 2026
- WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST 4.80M sh · $434.21M · Q2 2026
More on Boston Common Asset Management, LLC
FAQ
How long has Boston Common Asset Management, LLC held EW?
Boston Common Asset Management, LLC has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Boston Common Asset Management, LLC's current position in EW?
As of Q3 2026, Boston Common Asset Management, LLC holds 174.00K shares of EW (EDWARDS LIFESCIENCES CORP), valued at $15.02M, representing 0.88% of its reported portfolio and ranking #28.
Has Boston Common Asset Management, LLC been buying or selling EW?
In the latest 13F filing (Q3 2026), Boston Common Asset Management, LLC increased its position in EW. The position peaked in Q1 2024 at 205.27K shares.
Which other funds hold EW?
Other major institutional holders of EW include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, Aristotle Capital Management, LLC, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.